• Kyodo

  • SHARE

The Kyoto University Center for iPS Cell Research and Application has started creating induced pluripotent stem cells (iPS cells) for stockpiling for future use in regenerative medicine and clinical research, officials said.

The cell stockpiling project is being led by the center’s director, Shinya Yamanaka, an iPS cell developer and Nobel Prize winner, to build a stock of specific iPS cells with a lower risk of immune rejection.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.

SUBSCRIBE NOW

PHOTO GALLERY (CLICK TO ENLARGE)